PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,355,296 | -46.2% | 131,200 | -31.7% | 0.02% | -46.7% |
Q2 2023 | $2,519,388 | -70.7% | 192,173 | -75.0% | 0.03% | -74.4% |
Q1 2023 | $8,609,561 | +33.4% | 770,086 | +0.6% | 0.12% | +36.0% |
Q4 2022 | $6,455,677 | -29.4% | 765,798 | +39.6% | 0.09% | -32.8% |
Q3 2022 | $9,138,000 | +43.8% | 548,512 | +27.1% | 0.13% | +30.6% |
Q2 2022 | $6,354,000 | -43.9% | 431,632 | -5.5% | 0.10% | -46.7% |
Q1 2022 | $11,330,000 | -2.3% | 456,655 | +26.3% | 0.18% | +10.8% |
Q4 2021 | $11,597,000 | -4.2% | 361,607 | +7.5% | 0.17% | -16.2% |
Q3 2021 | $12,101,000 | -18.4% | 336,313 | +0.0% | 0.20% | -28.5% |
Q2 2021 | $14,836,000 | +153.2% | 336,273 | +162.5% | 0.28% | +113.1% |
Q1 2021 | $5,859,000 | -33.7% | 128,092 | +0.1% | 0.13% | -44.4% |
Q4 2020 | $8,833,000 | – | 127,976 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |